Skip to main content

Find Clinical Trials

Home
Conditions
Synucleinopathies

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,503 public trials 645 recruiting studies

Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

NCT05862649

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Rush University Chicago, Illinois, United States

AIBILI research center Coimbra, Portugal

Instituto de Biomedicina de Sevilla (IBiS) Seville, Spain

University Hospital Zürich Zurich, Switzerland

View Trial Details

Completed

Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects

NCT01994109

Conditions: Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Brain Diseases, +22 more
Locations: Loma Linda, California, United States

Los Angeles, California, United States

National City, California, United States

Aurora, Colorado, United States

View all 34 locations

View Trial Details

Completed

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

NCT02246374

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Phase 2a Study of VTX3232 in Parkinson's Disease

NCT06556173

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Local Site #840001 New Haven, Connecticut, United States

View Trial Details

Completed

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

NCT04928287

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Hope Biosciences Stem Cell Research Foundation Sugar Land, Texas, United States

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients

NCT05887466

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Completed

Rostock International Parkinson's Disease Study (ROPAD)

NCT03866603

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Tucson Neuroscience Research Tucson, Arizona, United States

Pharmacology Research Institute Encino, California, United States

Neuro-Pain Medical Center Fresno, California, United States

University of California (UC) San Diego La Jolla, California, United States

View all 110 locations

View Trial Details

Completed

Vestibulopathy as a Cause of Imbalance in Parkinson

NCT04768647

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Bacillus Subtilis in Parkinson's Disease

NCT06487975

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Norwegian Centre for Movement Disorders, Stavanger University Hospital Stavanger, Norway

NHS Lothian Edinburgh, United Kingdom

View Trial Details

Completed

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

NCT02071459

Conditions: Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +12 more
Locations: Centre hospitalier d'Angers Angers, France

CHU bordeaux Bordeaux, France

CHU de Clermont-Ferrand Clermont-Ferrand, France

CHU de Dijon Dijon, France

View all 13 locations

View Trial Details